Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ASXL1 antibody (C-Term)

This Rabbit Polyclonal antibody specifically detects ASXL1 in WB and ELISA. It exhibits reactivity toward Human and Mouse.
Catalog No. ABIN207586

Quick Overview for ASXL1 antibody (C-Term) (ABIN207586)

Target

See all ASXL1 Antibodies
ASXL1 (Additional Sex Combs Like 1 (ASXL1))

Reactivity

  • 26
  • 23
  • 1
Human, Mouse

Host

  • 26
  • 3
Rabbit

Clonality

  • 26
  • 3
Polyclonal

Conjugate

  • 16
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ASXL1 antibody is un-conjugated

Application

  • 19
  • 13
  • 12
  • 11
  • 10
  • 5
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 9
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    C-Term

    Specificity

    Synthetic peptide corresponding to C-terminal residues of human ASXL1 (Putative Polycomb group protein ASXL1)

    Purification

    Immunoaffinity purified

    Immunogen

    Synthetic peptide from human ASXL1.

    Type of Immunogen: Synthetic peptide
  • Application Notes

    Approved: ELISA, WB (1 μg/mL)

    Not recommended for: IHC-P

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    PBS, 0.01 % sodium azide, 50 % glycerol.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Aliquot to Avoid freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. Aliquot to avoid freeze/thaw cycles.
  • Target

    ASXL1 (Additional Sex Combs Like 1 (ASXL1))

    Alternative Name

    ASXL1

    Background

    Name/Gene ID: ASXL1

    Synonyms: ASXL1, BOPS, KIAA0978, MDS

    Gene ID

    171023

    UniProt

    Q8IXJ9

    Pathways

    Retinoic Acid Receptor Signaling Pathway
You are here:
Chat with us!